
For Successor Physicians
71%: Ophthalmology's Bonus Is a Procedure Count
Just over 7 in 10 ophthalmologists qualify for some kind of incentive bonus on top of base pay, according to Medscape's 2026 Ophthalmologist Compensation Report. Among that group, two factors decide almost everything: how many procedures they performed, and how many RVUs they generated doing them.
Ophthalmology's 71% sits comfortably inside the range other specialties report too, with dermatology and urology both near 74% and oncology close to 75%. Bonus eligibility itself isn't unusual across medicine. What's worth examining is what that eligibility is actually priced against, because a bonus sounds like a reward for good outcomes, sound judgment, or strong patient relationships. In practice, for most employed ophthalmologists, it functions closer to a piece rate. Do more volume, get more bonus. Do less, get less. Judgment, complexity, and quality barely enter the formula at all.
Why RVUs Won
Chad Stutelberg, national managing director of healthcare compensation and rewards at Arthur J. Gallagher & Co, estimates that roughly 85% of US physicians now have access to some form of productivity-based pay. That lines up with broader industry data. MGMA estimates roughly 70% of physicians nationally now have a wRVU productivity component built directly into their compensation, which means the formula underneath Stutelberg's figure is close to the default setting across American medicine, not an ophthalmology quirk at all.
In Medscape's report, Stutelberg is blunt about why RVUs specifically became the default measure. "RVUs are going to be by far the most common way of calculating these bonuses," he says. The reason has less to do with which measure best captures a physician's value, and more to do with which one is easiest for an employer to defend and hardest for a physician to dispute.
Stutelberg's explanation of the appeal is worth reading closely. Physicians may not love being evaluated on volume, but volume is something a physician can actually control day to day. A quality metric, by contrast, can feel entirely out of a physician's hands, shaped by patient mix, comorbidities, and other factors well outside the exam room. Employers gravitate toward the metric physicians can control, since it's simpler to administer and harder to contest than a quality measure with that many outside variables.
He's also careful to flag the downside of leaning on it too hard. Poorly designed incentive programs, he warns, can do real damage, and a bad bonus structure doesn't just fail to reward good work. It actively distorts behavior.
What the Research Actually Shows
That distortion isn't theoretical. Peer-reviewed research on physician compensation has found that RVU-based pay structures reliably increase service volume, and can push physicians toward more procedures with less weight on quality, contributing to burnout along the way. When the entire bonus formula runs through a volume count, the rational response to that formula is more volume, whether or not more volume is what a given patient actually needs.
Some of the country's most clinically respected health systems have deliberately moved away from a pure volume formula for this exact reason. Mayo Clinic and Cleveland Clinic have both built balanced scorecard approaches that weight quality and patient experience alongside productivity. Geisinger has gone further, tying as much as 20% of physician compensation to quality metrics rather than volume alone, and Intermountain has followed a similar path. All of them concluded that a compensation model built purely on volume tends to produce exactly the behavior you'd expect: more volume, regardless of whether the clinical picture calls for it.
Cataract Surgery Shows the Mechanism Clearly
Ophthalmology is a useful place to watch this play out, because so much of its volume runs through one procedure. Cataract surgery, billed under CPT code 66984, carries a fixed value of about 10.26 work RVUs under the current Medicare physician fee schedule, translating to roughly $336 in Medicare payment at this year's conversion factor. That fixed number, not the outcome, not the complexity of the particular eye, not how much judgment the case required, is what most employed ophthalmologists' bonus formulas are actually built around.
That transparency is exactly what makes the arrangement attractive to an employer and limiting for a physician. A formula this clean is easy to administer at scale across dozens or hundreds of employed physicians. It's also a hard ceiling. However skilled, efficient, or judicious a physician is, the bonus check only ever reflects a fraction of the RVU count, and the RVU count only ever reflects a fraction of the actual economic value that surgery generated.
Who Captures the Rest of That Value
Here's the part the bonus formula never touches. A cataract procedure generates a professional fee for the surgeon, but it also generates a facility fee, ancillary revenue from the surgical center, and, over time, real equity value in the practice or ASC where the procedure happened. An employed physician's RVU bonus only ever touches the first slice. The facility fee, the ancillary revenue, and the equity appreciation all flow to whoever owns the entity where the surgery took place, and for most employed ophthalmologists, that isn't them.
That's the actual story behind the 71% bonus-eligibility figure, even though the number sounds generous on its face. Being eligible for a bonus tied to procedure count means the upside is capped at a fraction of one slice of the value a physician's own clinical work creates. Ownership changes how many of those slices belong to the physician instead of the employer, while the RVU count underneath stays exactly the same.
The Formula Is Spreading Past the Bonus
The reach of this system isn't staying contained to the bonus line either. In this year's report, 35% of physicians overall said RVUs now shape their base pay directly, not just an incentive layered on top of it. The same volume count driving the bonus in this piece is starting to set the floor underneath it too, which means the ceiling and the floor are converging around the same formula, one that was never built to measure judgment in the first place.
The Pattern Across All Three Numbers
70% of ophthalmologists don't move their base pay much through negotiation, because a growing share of employers have made negotiation a closed policy rather than an open conversation. The specialty's $464,000 average sits well below what its own top earners take home, because ownership and facility structure, more than tenure, separate the two. And 71% of ophthalmologists have a bonus that pays for volume rather than judgment, capped by a formula someone else designed.
All three numbers describe the structure sitting on top of an ophthalmologist's clinical ability, and none of them describe the ability itself. That structure isn't fixed, and a physician doesn't have to accept it as permanent. Ownership is the one lever that touches all three numbers at once. It replaces a policy you don't set with pay you do, replaces a ceiling with the top of the range, and replaces a bonus counted in procedures with a share of everything the procedure actually generates.
Educational material only. Figures are illustrative and individual results vary. Statistics are drawn from the Medscape 2026 Ophthalmologist Compensation Report and cited third-party sources. See our Disclosures.
Written by
Verdira Team
Verdira is building a permanent home for ophthalmology practices. We write about succession, physician ownership, and the forces reshaping eye care in the United States.
Ready to secure your legacy?
We're here to ensure your hard work is valued and your business thrives as part of Verdira.
Disclosures
The content of this site is for general informational purposes only and is not intended to constitute an offer to sell or a solicitation to buy any security or other asset, or a promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.
The content of this site is for general informational purposes only and is not intended to constitute an offer to sell or a solicitation to buy any security or other asset, or a promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.
The content of this site is for general informational purposes only and is not intended to constitute an offer to sell or a solicitation to buy any security or other asset, or a promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.
© 2026 Verdira Management NY, LLC
